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Abstract
Background: Magnetic resonance imaging (MRI) is sensitive to early atherosclerotic changes such as positive remodeling in
patients with coronary artery disease (CAD). We assessed prevalence, quality, and extent of coronary atherosclerosis in a
group of healthy subjects compared to patients with confirmed CAD.
Methodology: Twenty-two patients with confirmed CAD (15M, 7F, mean age 60.4610.4 years) and 26 healthy subjects
without history of CAD (11M, 15F, mean age 56.164.4 years) underwent MRI of the right coronary artery (RCA) and vessel
wall (MR-CVW) on a clinical 1.5T MR-scanner. Wall thickness measurements of both groups were compared.
Principal Findings: Stenoses of the RCA (both , and $50% on CAG) were present in all patients. In 21/22 patients, stenoses
detected at MRI corresponded to stenoses detected with conventional angiography. In 19/26 asymptomatic subjects, there
was visible luminal narrowing in the MR luminography images. Fourteen of these subjects demonstrated corresponding
increase in vessel wall thickness. In 4/26 asymptomatic subjects, vessel wall thickening without luminal narrowing was
present. Maximum and mean wall thicknesses in patients were significantly higher (2.16 vs 1.92 mm, and 1.38 vs 1.22 mm,
both p,0.05).
Conclusions: In this cohort of middle-aged individuals, both patients with stable angina and angiographically proven
coronary artery disease, as well as age-matched asymptomatic subjects. exhibited coronary vessel wall thickening
detectable with MR coronary vessel wall imaging. Maximum and mean wall thicknesses were significantly higher in patients.
The vast majority of asymptomatic subjects had either positive remodeling without luminal narrowing, or non-significant
stenosis.
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Introduction
Coronary artery disease (CAD) remains the leading cause of
mortality and morbidity in the Western World and developing
countries despite continued improvements in prevention and early
diagnosis[1,2]. The most frequent cause underlying an acute
coronary event is disruption of an atherosclerotic plaque[3,4].
Rupture-prone plaques are referred to as thin-cap fibroatheroma
and characterized pathologically as having a large necrotic core,
high macrophage content and a thin, fibrous cap[3,4].
In asymptomatic individuals acute myocardial infarction and
sudden death may be the first clinical manifestation of coronary
atherosclerosis[5]. About 50–64% of all sudden cardiac deaths
occur without prior recognition of coronary heart disease[1]. Well-
established risk factors for coronary atherosclerosis are hypercho-
lesterolaemia, hypertension, cigarette smoking, diabetes mellitus,
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for global risk assessment, these parameters lack specificity for
prediction of individual coronary plaque burden.
Detection of subclinical coronary atherosclerosis in high-risk
patients might become an important strategy to prevent clinical
coronary heart disease. Compared to other imaging modalities
magnetic resonance imaging (MRI) has superior ability to
differentiate soft tissues and has shown to facilitate characteriza-
tion of atherosclerotic plaque components in the aorta and carotid
artery by using multisequence MRI[8,9,10]. These properties
make it uniquely suited for serial non-invasive imaging of the
vessel wall, and for monitoring effects of pharmaceuticals on
plaque progression or regression. Prior work has demonstrated the
capability of MRI to visualize the coronary vessel wall (CVW) with
high spatial resolution, as well as vessel wall thickening and
positive Glagov-type remodeling in patients[11,12,13].
In this study we sought to evaluate the prevalence and extent of
coronary atherosclerosis in a cohort of middle-aged subjects
without clinical CAD. MR coronary vessel wall (MR-CVW)
characteristics were compared to a positive control group of
patients with angiographically confirmed CAD.
Materials and Methods
Subjects
Between October 2005 and February 2007, 26 middle-aged
subjects without previous history or clinical symptoms of CAD and
25 patients with symptoms of stable angina and angiographically
confirmed CAD were enrolled. Healthy subjects were recruited via
newspaper advertisement. Patients were recruited from the
cardiology outpatient clinic of our hospital after having x-ray
coronary angiography (CAG). Patients with confirmed CAD
underwent MRI prior to percutaneous coronary intervention.
Hemodynamically unstable patients or patients with previous
interventions in the right coronary artery (RCA) as well as patients
with severe arrhythmia or contra-indications for MRI were
excluded. Approval of the Maastricht University Medical Center
review board and written informed consent of all participants were
obtained prior to inclusion.
In addition to registration of demographic data and risk factors,
the estimated glomerular filtration rate (eGFR) and PROCAM-
score[14] were calculated whenever data were available.
MR Imaging protocol
All MR studies were performed on a clinical 1.5T system
(Intera, Release 11.1 Philips Medical Systems, Best, The Nether-
lands) using a dedicated 5-element phased-array cardiac radiofre-
quency (RF) coil. Subjects were examined in the supine position.
First, localizer scans were obtained and the subject specific
middiastolic trigger delay and acquisition window were deter-
mined. These scans were followed by a double oblique oriented
three-dimensional (3D) bright blood balanced steady state free
precession (bSSFP) coronary MR angiography (CMRA) of the
RCA (TR/TE/FA: 6.2/3.1/120u, resolution: 0.9860.9863 mm).
In the same orientation, a vessel wall scan was acquired (3D FFE,
radial k-space sampling, modified double inversion recovery (DIR)
prepulse) as previously described[13,15,16]. Imaging parameters
for the vessel wall scan were: TR: 8 ms, repeated every other
heartbeat for good blood suppression, TE: 2.0 ms, Flip Angle: 30u,
Field of view: 3006300 mm and matrix: 3846384. Twenty
interpolated slices of 1 mm were obtained. The resulting
(acquired) spatial resolution was 0.7860.7862 mm. Cardiac
gating and a 2D navigator beam were used for compensation of
cardiac and respiratory motion. This protocol has previously been
shown to result in highly reproducible images of the coronary
vessel wall in healthy volunteers[16]. No contrast agents or
sublingual nitroglycerin were used.
Evaluation of coronary artery stenosis and plaque burden
Image quality (IQ) of the vessel wall datasets was scored by two
experienced, independent blinded observers on a 4 point scale:
1=well-defined vessel wall borders and high vessel wall-to-
background contrast; 2=some blurring of the vessel wall borders,
average to good vessel-wall to background contrast; 3=major
artifacts or severe blurring of the vessel wall borders, low to
average vessel wall-to-background contrast, and 4=vessel wall
cannot be identified, very low vessel wall-to-background contrast
(modified from Zhang et al. and Spuentrup et al.[17,18]). An
experienced cardiologist blinded to the results of the vessel wall
scans assessed the location and degree of a stenosis on the CMRA
images. Coronary artery luminograms were classified as negative
when there was no visible sign of disease or mild to moderate
luminal narrowing (stenosis ,50%). Significant disease (stenosis
$50%) was considered to be present in cases of obvious
narrowing of the vessel or marked attenuation of coronary lumen
signal[19]. X-ray coronary angiography (CAG) - available in all
CAD patients – was visually interpreted by different cardiologists
prior to MRI.
Subsequently, an observer blinded to clinical data quantitatively
analyzed coronary artery wall images. Minimum, mean and
maximum wall thickness were measured on the 3D vessel wall
sequence. Lumen diameter was measured on bSSFP images. For
measurements, a custom made software package was used
(VesselMASS, Leiden University Medical Center, department of
Radiology, division Image Processing, Leiden, the Nether-
lands)[20], adapted for viewing and analysis of longitudinal
coronary vessel wall images. For analysis purposes the RCA vessel
wall was divided into three segments according to the American
Heart Association classification[21].
To prevent errors in wall thickness and lumen diameter
measurements due to reconstruction errors, only source images
were used for measurements. In source images where the vessel
wall was visible, the inner and outer borders of the anterior and
posterior vessel wall were manually delineated (Figure 1). Each
resulting region of interest (ROI) was automatically divided in 100
subsegments for quantitative analysis of wall thickness. Because
measurements in adjacent subsegments are not independent due
to partial volume effects we corrected for the length of the
measured segment and spatial resolution by only using subseg-
ments from separate voxels and discarding measurements in
between. The number of included segments equals the number of
voxels in the ROI, which was calculated by dividing the length of
the ROI by the in-plane spatial resolution. Coronary plaque
burden was quantified as the mean and maximum RCA vessel
wall thickness along the proximal two vessel segments[19]. In
addition to measuring wall thickness, a normalized wall index was
calculated (100*(diameter lumen divided by the sum of anterior
and posterior wall thickness)) to get a better quantitative
impression about the degree of positive remodeling.
Based on both CMRA and MR-CVW, areas could be classified
as diseased or not-diseased according to the following criteria:
ROIs with vessel wall thickening were classified as diseased. This
could either be in areas of stenosis (combination of luminal
narrowing with vessel wall thickening) or in areas with positive
remodeling (wall thickening without luminal narrowing. ROIs
with normal lumen diameter compared to the rest of the vessel and
with a vessel wall that had no areas of focal wall thickening or focal
high signal intensity, were classified as ‘‘not diseased’’. Since
Coronary Vessel Wall MRI
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sequences and can therefore be difficult to visualize, ROIs with
obvious luminal narrowing but without visible vessel wall
thickening were interpreted as diseased with (heavily) calcified
plaque if overall image quality of the vessel wall scan was good and
if the vessel wall and lumen could be distinguished in other
segments of the vessel.
Statistical analysis
Statistical analysis was performed using SPSS 11.5 (SPSS Inc.,
Chicago, IL, USA). Differences in IQ between the patient and
control group were compared using a Wilcoxon rank-sum test.
Minimum, maximum and mean wall thickness and the normalized
wall index in both groups were compared using an unpaired
student t-test. Differences between men and women in both groups
were analyzed using a Wilcoxon rank-sum test.
In addition, we pooled the results by testing the global
hypothesis that all results of the measurements (minimum,
maximum and mean values) of vessel wall thickness were equal
using the ordinary least square test[22,23]. Significance was
assumed at two-tailed p values of less than 0.05.
Results
Subject characteristics
All 51 subjects underwent coronary MRI without complica-
tions. In three patients, the coronary vessel wall sequence could
not be performed due to severe back pain (1 patient) and software
problems (2 patients). This resulted in evaluable vessel wall scans
in 26 asymptomatic subjects (11 M, mean age 5664 yrs) and 22
patients (15 M, mean age 60610 yrs).
Clinical characteristics of this study cohort are listed in table 1.
There was a significant difference in subjects’ weight and the
presence of hypercholesterolemia and hypertension between both
groups. In the patient group, there was a trend towards higher
prevalence of males and higher age, higher incidence of diabetes,
and higher PROCAM score. In patients (n=12) in whom a
PROCAM score could be calculated, a 10-year risk for acute
coronary events of 12.0% (68.1, range: 1.3–25.1%) was present,
versus 4.8% (62.4, range: 1.9–8%) in control subjects (n=6).
Linear regression showed a weak correlation between eGFR and
mean wall thickness (R: 0.54, p,0.01). In subjects with low eGFR
decreased vessel wall thickness was found.
Figure 1. Measurement of vessel wall thickness and signal intensity on source images. The anterior and posterior vessel walls are
delineated (A). In each segment 100 measurements are made of the thickness and signal intensity of the proximal and distal RCA vessel wall and the
diameter of the lumen (B,C). The custom made software program calculates wall thickness, signal intensity, and lumen diameter (D–F) over the entire
length of the measured segment.
doi:10.1371/journal.pone.0012998.g001
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The prevalence of coronary stenoses as identified by CMRA in
the 48 subjects with complete scans is listed in Table 2. Significant
coronary artery stenoses ($50%) were found in 17 patients on
CMRA, but only in 16 patients on CAG. In 19/26 asymptomatic
subjects (73%), there was evidence of at least some luminal
narrowing on CMRA. Nine of these 19 asymptomatic subjects had
a significant stenosis ($50%). In the patient group, the degree of
stenosis as estimated on CMRA (, or $ than 50%) was compared
to the results of CAG. In 21 out of 22 patients (95%), location of
stenoses detected on CMRA corresponded to stenoses detected
with CAG, although in some segments there was overestimation of
the degree of stenosis on CMRA. Agreement between CAG and
CMRA for detection of lesions is demonstrated in table 3.
Sensitivity and specificity were 100% and 83%, respectively.
Lumen diameter as measured on MR-CVW, was slightly
smaller compared to diameters measured on CMRA. In patients,
lumen diameter on CMRA was 1.8660.46 mm, versus
1.6660.53 mm on MR-CVW (p=0.02). In asymptomatic sub-
jects, lumen diameter was 2.0160.55 on CMRA and 1.6460.63
on MR-CVW (p,0.01). The slight difference in in-plane spatial
resolution between both techniques (0.99 mm on CMRA,
0.78 mm on MR-CVW), can theoretically lead to overestimation
of the lumen diameter on CMRA, but also overestimation of
coronary stenoses, or underestimation of lumen diameter on MR-
CVW. However, on MR-CVW partial volume may play a more
important role since the lumen is surrounded by vessel wall. It is
more probable that lumen measurements are more accurate on
CMRA, although a slight influence of the signal of the vessel wall
on diameter measurements on CMRA cannot be ruled out
completely. In theory however, we expect that this effect is
minimal due to the technique used for suppression of myocardial
signal (T2prep). Since the vessel wall is mainly composed of
smooth muscle cells, collagen and elastin, the T2 is expected to be
similar to the T2 of myocardium. Because of signal suppression
due to T2prep, only little signal contribution of the vessel wall can
be expected.
There was a trend towards smaller minimum lumen diameter as
measured on the luminography sequence in the patient group
(1.0660.58 in patients vs 1.3560.53 mm in asymptomatic
subjects, p=0.08). However, no significant differences could be
demonstrated between mean (1.8660.46 mm in patients,
2.060.55 mm in asymptomatic subjects, p=0.35) and maximum
(2.9160.57 mm in patients, 2.7360.70 mm in subjects, p=0.35)
luminal diameters of the two groups (Table 4).
IQ of the vessel wall scans was good in the majority of cases with
a mean score of 1.4260.58 for all subjects. There was no
significant difference in IQ between patients and asymptomatic
subjects (1.3260.57 vs 1.560.58 for observer 1, p=0.21,
1.4260.58 vs 1.4160.59 for observer 2, p=0.9).
Various degrees of non-uniform vessel wall thickening were seen
on the MR-CVW scans in patients and asymptomatic subjects
(Figures 2 and 3). Quantitative results are summarized in Table 4.
Maximum and mean wall thicknesses were significantly larger in
the patient group. The normalized wall index was higher in
asymptomatic subjects when compared to patients (82.8 6 20.7
versus 68.2 6 17.0, p=0.012), representing an increased wall
thickness in all patients and asymptomatic subjects but a relatively
thicker vessel wall compared to lumen diameter in patients. Pooled
results of wall thickness also demonstrated a significant difference
between the groups (p=0.03).
Overall, there was good agreement between luminal narrowing
at CMRA and increased wall thickness at MR-CVW in all
patients. Agreement between CMRA and MR-CVW in asymp-
tomatic subjects is demonstrated in Table 5. There were 5
asymptomatic subjects with stenoses without wall thickening: in
Table 1. Subject characteristics.
Patients
(N=22)
Asymptomatic
subjects
(N=26) P
characteristics
Gender, male n (%) 15 (68) 11 (42) 0.08
Age, y (6SD) 60.41 (10.35) 56.08 (4.43) 0.08
Weight, kg (6SD) 81.27 (15.59) 71.35 (13.73) 0.02
Systolic blood pressure,
mm Hg (6SD)
137 (14.16) 133 (16.38) 0.39
Diastolic blood pressure,
mm Hg (6SD)
80 (9.28) 79 (11.46) 0.87
Diabetes, n (%) 3 (13.6) 0 (0) 0.08
Current smoker, n (%) 3 (13.6) 5 (19.2) 0.61
Hypertension, n (%) 13 (59.1) 1 (3.8) ,0.01
Hypercholesterolemia, n (%) 11 (50) 2 (7.7) 0.01
eGFR (6SD) mL*min
22*
1.73 m
22
88.61 (27.5)
(n=22)
76.01 (24.2)
(n=9)
0.24
PROCAM-score (6SD)
{ 44.6 (9.7)
(n=12)
36.0 (6.0)
(n=6)
0.07
*eGFR: estimated Glomerular Filtration Rate.
{PROCAM-score: based on the PROspective CArdiovascular Muenster
study-scoring scheme.
doi:10.1371/journal.pone.0012998.t001
Table 2. Stenoses on coronary MRA.
Patients
(N=22)
Asymptomatic
Subjects (N=26)
No stenoses 0 (0) 7 (27)
,50% stenoses 5(23) 10 (38)
$50% stenoses 17 (77) 9 (35)
Prevalence of stenoses (number (%)) in the right coronary artery as seen with
coronary MRA.
doi:10.1371/journal.pone.0012998.t002
Table 3. Comparison between CMRA and CAG on segment
level.
CAG
Non-evaluable
segments
0–50% $50%
CMRA proximal ,50%
$50%
10
2
0
10
0
CMRA mid (*) ,50%
$50%
10
3
0
8
1 (CAG)
CMRA distal ,50% 10 0 4 (CMRA)
1 (CAG)
$50% 5 2
Agreement between coronary MRA (CMRA) and X-ray coronary angiography
(CAG) on degree of stenoses in the right coronary artery in patients with
coronary artery disease (N=22) in the proximal, mid and distal RCA. Values
represent number of segments.
doi:10.1371/journal.pone.0012998.t003
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on the vessel wall scan, in one subject vessel wall and lumen could
hardly be distinguished and in one subject the location of the vessel
wall thickening did not correspond to the area of stenosis on
CMRA.
The groups were age-matched, but not matched for gender.
There was a trend towards a higher prevalence of women in the
group of healthy volunteers (Table 1). In patients, there were no
significant differences between men and women. However, in the
group of healthy volunteers, there was a significant difference in
mean vessel wall thickness, mean luminal diameter on CMRA,
mean luminal diameter on MR-CVW and a trend towards
difference in normalized wall index (Table 6).
Discussion
This is one of the few studies to use non-invasive MRI to assess
coronary artery plaque burden in an asymptomatic population-
based cohort of adults using magnetic resonance CVW imaging.
The most significant finding of this study is the high prevalence of
coronary wall plaque in asymptomatic adults free of known CAD.
Four out of 26 healthy subjects exhibited evidence of positive
remodeling without luminal narrowing and the majority of
subjects (19/26) exhibited evidence of luminal narrowing at
CMRA, in some cases even exceeding 50%. As expected, the
burden of coronary atherosclerosis was higher in the positive
control group, which consisted of patients with angiographically
confirmed CAD. Despite the lack of a gold standard for
visualization of the coronary vessel wall (i.e. intravascular
ultrasound), these data suggest that MRI may help to non-
invasively identify not only late stages of atherosclerosis but also
the early manifestations of atherosclerotic disease in the coronary
vessel wall.
Our results corroborate the findings of Kim et al, who
investigated subjects with longstanding diabetes type 1 but without
cardiovascular symptoms[19]. In these asymptomatic patients,
only 10% of patients with nephropathy and 0% of patients with
normoalbuminuria had evidence of coronary stenoses although
the prevalence of visually identifiable coronary plaque in the RCA
was higher (76% in patients with nephropathy versus 15% in
patients with normoalbuminuria). The prevalence of vessel wall
thickening in the RCA is in the same range as in our study group,
however, we found more cases of luminal narrowing, probably
reflecting differences in study populations. Although diabetic
subjects tend to have more atherosclerosis, our asymptomatic
subjects were older than the subjects with diabetic nephropathy
from the study by Kim et al (mean age of 56 vs 48 years).
Additionally, MRI is known to overestimate stenosis and possible
slight differences in spatial resolution between the used techniques
can contribute to differences in assessment of stenosis. Tuzcu et
al[24] studied a population of 262 subjects and found vessel wall
thickening of more than 0.5 mm on intravascular ultrasonography
(IVUS) in .70% of asymptomatic subjects by the age of 40, while
only 8% of X-ray coronary angiograms of the entire cohort
demonstrated mild luminal irregularities. While the study by
Tuzcu once again underscores that early vessel wall abnormalities
go undetected at coronary angiography, there was a large
difference in prevalence of luminal irregularities compared to
our study. The fact that our study demonstrated luminal
irregularities on CMRA in .70% of subjects compared to 8%
in the study by Tuzcu et al. can be explained by the better spatial
resolution of X-ray coronary angiography compared to CMRA,
the fact that flow disturbances on CMRA can lead to
overestimation of the degree of stenoses, and the difference in
age and case-mix between the populations.
A recent publication from the Multi-Ethnic Study of Athero-
sclerosis (MESA) also found positive remodeling in a large cohort
of 179 subjects without known coronary artery disease[25]. In
contrast to our study, the MESA study did not find any significant
stenoses ($50%), despite the use of similar spatial resolution as
well as an identical technique for suppressing blood flow[25]. Axial
images of all three coronary arteries (LM, RCA and LAD) were
acquired, but due to time constrains this was limited to the
proximal parts of the vessels of interest, with only one slice in the
LM and 3 slices in the RCA and LAD. Axial imaging of the
coronary vessel wall is very time consuming, and the longitudinal
technique that we used offers an overview of the vessel wall in a
much larger part of the coronary artery of interest. The difference
in acquisition approach, especially the chosen imaging plane and
resulting differences in partial volume artefacts, between our study
and the MESA study is one of the likely explanations for the
discordant results.
Clinical CAD has a long asymptomatic period during which
biological risk factors interact with genetic and environmental
influences to initiate and promote the development of coronary
atherosclerotic plaque[26,27]. Once established, atherosclerosis
can exist in a subclinical state characterized by the presence of
plaque but an absence of clinical signs and symptoms. Acute
clinical manifestations of coronary atherosclerosis such as unstable
angina and myocardial infarction are usually the consequence of
acute rupture of the atherosclerotic plaque, leading to exposure of
Table 4. Vessel wall thickness and lumen diameter
measurements.
Patients
(N=22)
Asymptomatic
subjects
(N=26) p
Vessel wall:
Minimal vessel wall thickness (mm)
(6SD)
0.71 (0.19) 0.65 (0.16) 0.269
Maximal vessel wall thickness (mm)
(6SD)
2.16 (0.37) 1.92 (0.44) 0.048
Mean vessel wall thickness (mm)
(6SD)
1.38 (0.18) 1.22 (0.22) 0.011
Overall (standardized) wall thickness
(6SD)
0.87 (2.25) 20.74 (2.57) 0.026
Lumen CMRA
Minimal lumen diameter (mm)
(6SD)
1.06 (0.58) 1.35 (0.53) 0.080
Maximal lumen diameter (mm)
(6SD)
2.91 (0.57) 2.73 (0.70) 0.354
Mean lumen diameter (mm) (6SD) 1.86 (0.46) 2.01 (0.55) 0.346
Lumen MR-CVW
Minimal lumen diameter (mm)
(6SD)
0.91 (0.58) 1.02 (0.53) 0.475
Maximal lumen diameter (mm)
(6SD)
2.57 (0.66) 2.39 (0.81) 0.396
Mean lumen diameter (mm) (6SD) 1.66 (0.53) 1.64 (0.63) 0.930
Normalized wall index (%), (6SD) 68.2 (17.0) 82.8 (20.7) 0.012
Vessel wall thickness and lumen diameter measurements (6SD) measured on
both CMRA and MR-CVW in patients and healthy volunteers. Normalized wall
index was calculated as a value to represent positive remodeling according to
the following formula: 100*(lumen diameter/sum of anterior and posterior wall
thickness).
doi:10.1371/journal.pone.0012998.t004
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thrombus formation[28]. Although traditional risk factors and risk
scores such as the Framingham[7,29] and PROCAM[14] scores
are accurate at predicting risk to experience a cardiovascular event
in the near future for groups of patients, they often lack
discriminative power to characterize individual subjects risk.
Approximately 40% of the adult population in the U.S. and
Western Europe are at intermediate (0.5–2.0%) and 10% at high
risk (.15%) for developing an acute coronary event over the next
decade[30]. Therefore, further risk stratification of individual
patients with CAD using novel biochemical markers as well as
noninvasive imaging techniques may be important. Our study was
motivated by the paucity of data on the prevalence and
characteristics of early CAD and coronary atherosclerotic plaque
burden at MRI in an unselected cohort of asymptomatic middle
aged adults free of known CAD at baseline. However, it is known
that the measured degree of coronary stenosis that was taken as
significant in this study (i.e. $50%) often is not associated with
significant impairment in coronary blood flow. This might be the
reason why none of the control subjects with stenoses $50% at
MRI were symptomatic. An alternative explanation could be that
with MRI luminal irregularities are erroneously overestimat-
ed[31,32,33], which is one of the shortcomings of MRI in
comparison to conventional X ray angiography.
Whether MR-CVW confers additional information over more
established non-invasive imaging techniques such as calcium
scoring[34,35] and multislice computed tomography (MSCT)
[36,37] is unknown. Spatial resolution of CT is better. However,
in comparison to epicardial coronary artery calcium scoring, MRI
can detect earlier changes such as outward remodeling. Outward
remodeling has been shown to be associated with plaques that
have a higher relative content of fibrofatty components as opposed
to calcification[38], as well as with plaques that ultimately exhibit
an unstable clinical presentation[39]. The excellent soft-tissue
resolution of MRI enables better characterization of plaque
components than CT. Furthermore, no contrast agents are needed
to visualize the coronary vessel wall with MRI, which is beneficial
in patients with renal failure or allergies. An additional advantage
of MRI is that it does not require radiation exposure, an issue that
takes on considerable importance when weighing risks and benefits
in asymptomatic subjects, and when follow-up studies are
desired[40].
Limitations of this study should be considered. Due to ethical
considerations, no comparison to a standard of reference was
obtained in asymptomatic volunteers and therefore, there is no
certainty about actual prevalence of abnormalities in this group.
Furthermore, the groups were matched for age but not for gender.
It is known that there are gender related differences in coronary
artery disease. In general, women have a less typical clinical
presentation and often have fewer angiographic high-risk
features[41,42]. In our group of asymptomatic volunteers, there
were several significant differences between men and women.
Figure 2. MRA and MR-CVW in asymptomatic subjects. Balanced steady state free precession (bSSFP) coronary MRA (A,C) and corresponding
vessel wall scans (B,D) of the right coronary artery (RCA) in asymptomatic subjects. A and B represent the RCA of a 62 y/o female (A,B). There is a thin
vessel wall with uniform signal intensity (arrows in B). In C and D, the RCA of a 54 y/o female is shown. In this subject, the posterior proximal vessel
wall is thicker and has higher signal intensity compared to the anterior vessel wall (arrows in D), indicating the presence of positive remodeling. Ao
indicates aorta.
doi:10.1371/journal.pone.0012998.g002
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however, the lower normalized wall index in women indicates a
relatively thick vessel wall compared to lumen diameter, which
could be related to more positive remodeling. In patients, these
differences between men and women were not found. Our results
are supported by the study by Miao et al. who also found gender
related differences in lumen size, vessel wall area and mean vessel
wall thickness in a large cohort of asymptomatic men and women
who underwent MRI of the coronary vessel wall [25]. However,
in both men and women, they found a similar, significant,
relationship between vessel wall thickness and outer lumen area or
lumen area, both measures for the degree of positive remodeling.
In the study by Miao et al, there was no comparison between
patients with CAD and healthy subjects. Due to the difference in
the amount of women between both groups in our study, future
Figure 3. MRA and MR-CVW in patients with stable angina. X-ray coronary angiography (A,D), balanced steady state free precession (bSSFP)
coronary MRA(B,E)andcorresponding vesselwall scans(C,F)oftheright coronaryartery(RCA)in twopatientswith stable angina. Ina 40 y/omale(A–C),
vessel wall thickness and signal intensity are increased in areas of stenosis and wall irregularities (arrows). In a 67 y/o female (D–F) the culprit lesion was
located intheleft anterior descending artery(notimaged).However, theproximal RCA demonstrated wallfocal luminalirregularities(arrowsin D,E).InF,
corresponding focal heterogeneity in wall thickness and signal intensity of the entire vessel wall are clearly visible. Ao indicates aorta.
doi:10.1371/journal.pone.0012998.g003
Table 5. Agreement between MR coronary vessel wall
imaging (MR-CVW) and coronary magnetic resonance
imaging (CMRA) for detection of stenoses and vessel wall
thickening in asymptomatic volunteers.
CMRA
No stenoses Stenoses
MR-CVW No Wall thickening 3 5
Wall thickening 4 14
Values represent number of subjects.
doi:10.1371/journal.pone.0012998.t005
Table 6. Gender related differences in the group of patients
(n=22) and the group of healthy volunteers (n=26).
Men Women p
Patients (15M, 7F)
Mean vessel wall thickness (mm) (6SD) 1.41 (0.18) 1.32 (0.18) 0.341
Lumen diameter on CMRA (mm) (6SD) 1.90 (0.38) 1.79 (0.61) 0.307
Lumen diameter on MR-CVW (mm) (6SD) 1.66 (0.49) 1.65 (0.63) 0.805
Normalized wall index (%), (6SD) 67.8 (13.0) 69.1 (24.9) 0.916
Healthy subjects (11M, 15F)
Mean vessel wall thickness (mm) (6SD) 1.34 (0.24) 1.14 (0.18) 0.046
Lumen diameter on CMRA (mm) (6SD) 2.43 (0.57) 1.69 (0.26) 0.001
Lumen diameter on MR-CVW (mm) (6SD) 2.04 (0.75) 1.36 (0.31) 0.005
Normalized wall index (%), (6SD) 94.0 (26.6) 74.6 (9.3) 0.092
doi:10.1371/journal.pone.0012998.t006
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study possible gender-related differences.
Currently, there are still some limitations in scan technique for
coronary vessel wall imaging. With currently used in-plane spatial
resolution of 0.78 mm, detection of small variations in wall
thickness due to partial volume effects are not yet possible.
Additionally, due to the current spatial resolution, it can be
expected that partial volume effects account for overestimation of
coronary vessel wall thickness. Other factors that lead to
overestimation of wall thickness are curvature of the vessel and
out of plane orientation of the vessel. However, these factors play a
more important role with multiplanar reformatting, and to
minimize errors due to these factors, measurements were
performed on source images.
Furthermore, because the obvious long-term goal of MR-CVW
imaging is not only measurement of plaque size but also
composition, increased spatial resolution is needed to characterize
plaque components. This is important, as it is known that a large
lipid-rich necrotic core and a thin fibrous cap portend a poor
prognosis. First attempts at characterization of coronary plaques
using contrast-enhanced MR-CVW imaging have been made by
Maintz et al[43] and Yeon et al[44], who demonstrated that use of
contrast-enhanced MR CVW imaging allowed identification of
areas of delayed enhancement that correlated with severity of
atherosclerosis by MSCT and quantitative X-ray angiography.
Also, whether therapeutic intervention guided by imaging modal-
ities will influence clinical event rates remains an important focus
of research. Imaging cannot be regarded as an isolated tool to
determine prognosis. However, it is highly likely that imaging will
only confer additional information in selected subgroups of subjects
in combination with traditional risk factors and (novel) serological
markers. This concept is also known as the ‘vulnerable patient’[45].
Further limitations include the relatively low sample size and,
because of an attempt to limit total scantime in our subjects, analysis
of coronary plaque burden was restricted to the RCA.
In conclusion, although there was low prevalence of significant
coronary stenoses, we found coronary atherosclerotic plaque in a
large proportion of asymptomatic middle-aged subjects at MR
CVW imaging. As expected, there were less stenoses and
asymptomatic subjects exhibited lower mean coronary vessel wall
thickness compared to a control group of patients with
angiographically proven coronary artery disease. Because the
time-course from subclinical disease to clinical events is highly
variable, it is important that future studies focus on the association
between MR CVW evidence of disease and clinically manifest
incident CAD.
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